T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CXO
76
DELISTED
CONCHO RESOURCES INC.
CXO
| $2.14B | 0.3% |
20,730,550
+6,853,820
| +49% | +$740M |
|
77
Ball Corp
BALL
$16.6B
| $2.12B | 0.3% |
30,341,431
-1,824,743
| -6% | -$113M |
|
|
FITB
78
Fifth Third Bancorp
FITB
$52.2B
| $2.09B | 0.29% |
75,045,095
-641,529
| -0.8% | -$17.6M |
|
79
Gen Digital
GEN
$17.4B
| $2.06B | 0.29% |
94,745,012
-829,534
| -0.9% | -$17.8M |
|
80
Verizon
VZ
$196B
| $2.03B | 0.29% |
35,596,765
-15,827,733
| -31% | -$912M |
|
81
TC Energy
TRP
$66.3B
| $2.03B | 0.29% |
41,029,204
-7,080,183
| -15% | -$339M |
|
|
HOLX
82
DELISTED
Hologic
HOLX
| $2.03B | 0.28% |
42,197,163
+116,925
| +0.3% | +$5.41M |
|
83
Nike
NKE
$61.3B
| $2.02B | 0.28% |
24,003,576
-615,463
| -2% | -$51.8M |
|
|
84
Linde
LIN
$226B
| $2.01B | 0.28% |
10,000,888
+7,159,363
| +252% | +$1.34B |
|
85
Teleflex
TFX
$5.91B
| $1.99B | 0.28% |
6,001,461
-29,754
| -0.5% | -$8.98M |
|
86
S&P Global
SPGI
$120B
| $1.94B | 0.27% |
8,533,366
-353,571
| -4% | -$77.2M |
|
87
Southern Company
SO
$106B
| $1.94B | 0.27% |
35,038,301
-1,618,891
| -4% | -$86.7M |
|
88
Merck
MRK
$322B
| $1.92B | 0.27% |
24,036,119
-8,582,035
| -26% | -$657M |
|
89
Microchip Technology
MCHP
$44B
| $1.91B | 0.27% |
44,089,698
-16,609,572
| -27% | -$738M |
|
|
WCG
90
DELISTED
Wellcare Health Plans, Inc.
WCG
| $1.91B | 0.27% |
6,690,491
-556,180
| -8% | -$153M |
|
91
Agilent Technologies
A
$42.2B
| $1.85B | 0.26% |
24,781,634
-2,004,190
| -7% | -$148M |
|
|
ALXN
92
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.84B | 0.26% |
14,085,352
-75,257
| -0.5% | -$9.7M |
|
93
Cooper Companies
COO
$15B
| $1.84B | 0.26% |
21,799,588
-1,282,600
| -6% | -$96.4M |
|
94
Air Products & Chemicals
APD
$68.9B
| $1.81B | 0.25% |
8,007,920
-2,175,495
| -21% | -$450M |
|
|
PXD
95
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.79B | 0.25% |
11,623,503
+3,032,727
| +35% | +$465M |
|
|
DATA
96
DELISTED
Tableau Software, Inc.
DATA
| $1.76B | 0.25% |
10,581,681
-1,063,922
| -9% | -$140M |
|
97
Revvity
RVTY
$12.9B
| $1.74B | 0.24% |
18,076,467
-966,700
| -5% | -$90.1M |
|
98
Burlington
BURL
$22.6B
| $1.74B | 0.24% |
10,213,395
+39,084
| +0.4% | +$6.39M |
|
|
EA
99
DELISTED
Electronic Arts
EA
| $1.7B | 0.24% |
16,746,228
-937,450
| -5% | -$89.3M |
|
100
Centene
CNC
$32.1B
| $1.68B | 0.24% |
32,063,972
-971,800
| -3% | -$52.5M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.